← Back to headlines
Amylyx Stock Surges After GLP-1 Blocker Hits All Trial Goals
Amylyx stock experienced a significant 55% surge following the announcement that its GLP-1 blocker successfully met all trial goals.
18 Aug, 18:11 — 18 Aug, 18:11
Sources
Showing 1 of 1 sources
Related Stories
Irish Health Agency Fined €645,000 for Storing Records in Derelict Sites
1h ago
New Urine Test Detects Over 90 Percent of Bladder Cancer Cases
2h ago
Swimmer Hospitalized Following Suspected Shark Attack in Massachusetts
5h ago
Wellington Clinics Suspends Kidney Transplants Amid Organ Harvesting Probe
11h ago